Simplify the identification of cancer research targets in cell free fluids
Analyzing circulating tumor DNA (ctDNA) offers a non-invasive, dynamic window into the body’s physiological state and its use as a biomarker is gaining rapidly. However, multiple challenges remain with establishing its routine application. This is mainly due to its low levels, high rates of fragmentation, and preanalytical variabilities associated with sample collection, ctDNA extraction and quantification. Read on to learn how you can establish a reliable ctDNA workflow from plasma samples.
For research use only. Not for use in diagnostic procedures.
Plasma fractionation for ctDNA research
Reproducible cfDNA extraction with chemagic technology
cfDNA library prep kit
Please note that product labeling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.